Regel Therapeutics Appoints Stephen J. Farr as New Chief Executive Officer
CAMBRIDGE, Mass. and BERKELEY, Calif., June 20, 2024 /PRNewswire/ -- The Board of Directors of Regel Therapeutics, a gene regulation company, announced that Stephen J. Farr, PhD, begins today as Chief Executive Officer (CEO). Dr. Farr served as …